Lactic Acidosis in IDDM Children Treated with Biguanides
Bao Meizhen
Abstract
Bao Meizhen
Abstract
Objective:In order to explore the lactic level and frequency of lactic acidosis (LA) as side effects of biguanide drugs. Methods:33 inpatients of IDDM children were treated with biguanides during Feb. 1996 to Oct. 1997.The dosage of phen-formin was 25 mg tid;or metformin 250 mg tid. Results:Only one case (3% ) had lactic acidosis (lactic level5 mmol/L); 10 patients (30.3%) had hyperlacticemia (lactic level 3 mmol/L); 21 patients (63.3%) had diabetes ketoacidosis (DKA). When DKA and LA were abolished with insulin therapy and liver and kidney functions were normal, biguanides had been given to them (phenformin for 29 cases; metformin for 4 cases). Before and after the treatment, the blood lactic levels showed no differences (t = 1.45,P0.05). Rectilinear correlation analysis showed that there is negative correlation be-tween insulin dosage and time (r= - 0.980 5, P 0.01) . Combination of biguanide agent and insulin therapy may decrease the dosage of insulin by 2/3 ~ 3/4. Conclusion: IDDM children treated with insulin and biguanide drugs, if dosage of bigua-nide was appropriate (phenformin 75 mg/d, metformin 750 mg/d) the blood lactic level would not be abnormal. Therefore biguanide agents could be a safe, effective treatment for IDDM,and reduced the sufferings caused by insulin injection and cost of medication.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:In order to explore the lactic level and frequency of lactic acidosis (LA) as side effects of biguanide drugs. Methods:33 inpatients of IDDM children were treated with biguanides during Feb. 1996 to Oct. 1997.The dosage of phen-formin was 25 mg tid;or metformin 250 mg tid. Results:Only one case (3% ) had lactic acidosis (lactic level5 mmol/L); 10 patients (30.3%) had hyperlacticemia (lactic level 3 mmol/L); 21 patients (63.3%) had diabetes ketoacidosis (DKA). When DKA and LA were abolished with insulin therapy and liver and kidney functions were normal, biguanides had been given to them (phenformin for 29 cases; metformin for 4 cases). Before and after the treatment, the blood lactic levels showed no differences (t = 1.45,P0.05). Rectilinear correlation analysis showed that there is negative correlation be-tween insulin dosage and time (r= - 0.980 5, P 0.01) . Combination of biguanide agent and insulin therapy may decrease the dosage of insulin by 2/3 ~ 3/4. Conclusion: IDDM children treated with insulin and biguanide drugs, if dosage of bigua-nide was appropriate (phenformin 75 mg/d, metformin 750 mg/d) the blood lactic level would not be abnormal. Therefore biguanide agents could be a safe, effective treatment for IDDM,and reduced the sufferings caused by insulin injection and cost of medication.
Key concepts: Biguanide, Lactic acidosis, Phenformin, Metformin, Medicine, Insulin, Internal medicine, Diabetes mellitus